Addex Therapeutics (ADXN) Stock Chart & Stock Price History $9.28 +0.15 (+1.59%) As of 07/3/2025 01:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Addex Therapeutics Stock Price Performance The Addex Therapeutics (ADXN) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 6.98%, with a year-to-date return of 32.50%. In the past month, the stock has decreased 9.34%, reflecting recent market activity. As of the latest close, Addex Therapeutics traded at $9.28 with a market cap of $9.83 million and volume of 28,993 shares. Receive ADXN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Addex Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-1.59%1 Month Performance-9.34%3 Month Performance+24.26%Year-To-Date Performance+32.50%1 Year Performance+6.98% ADXN Stock Chart for Sunday, July, 6, 2025 ADXN Chart by TradingView Addex Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/04/2025$9.28$9.28$9.89$8.9928,993 shs$9.83 million07/03/2025$9.58$9.28-3.13%$9.89$8.9928,993 shs$9.83 million07/02/2025$9.43$9.58+1.59%$9.80$9.0514,874 shs$9.75 million07/01/2025$9.41$9.43+0.16%$9.87$8.9944,098 shs$9.99 million06/30/2025$8.96$9.41+5.02%$9.80$8.8051,904 shs$9.98 million06/27/2025$8.87$8.96+1.07%$9.80$8.5060,692 shs$9.50 million06/26/2025$8.72$8.87+1.72%$9.20$8.549,539 shs$9.40 million06/25/2025$8.68$8.72+0.40%$9.16$9.16292 shs$9.24 million06/24/2025$8.68$8.68+0.06%$9.13$8.2310,982 shs$9.20 million06/23/2025$8.88$8.68-2.30%$9.23$8.0342,246 shs$9.20 million Get the Latest News and Ratings for ADXN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Addex Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 06/20/2025$8.90$8.88-0.18%$9.78$8.021,373 shs$9.41 million06/19/2025$8.90$8.90$9.20$8.201,390 shs$9.43 million06/18/2025$8.50$8.90+4.65%$9.20$8.201,390 shs$9.43 million06/17/2025$8.00$8.50+6.24%$8.90$8.391,284 shs$9.01 million06/16/2025$8.24$8.00-2.95%$8.38$8.312,636 shs$8.48 million06/13/2025$8.11$8.24+1.65%$8.38$8.312,636 shs$8.74 million06/12/2025$8.74$8.11-7.21%$9.02$8.115,240 shs$8.60 million06/11/2025$8.57$8.74+1.98%$9.01$9.011,339 shs$9.26 million06/10/2025$9.89$8.57-13.31%$9.00$8.428,898 shs$9.08 million06/09/2025$10.23$9.89-3.36%$11.00$9.658,140 shs$10.48 million06/06/2025$8.15$10.23+25.51%$11.31$8.7350,533 shs$10.84 million06/05/2025$8.08$8.15+0.94%$8.57$8.281,259 shs$8.64 million Related Companies Karyopharm Therapeutics Stock Price Chart Eagle Pharmaceuticals Stock Price Chart Acrivon Therapeutics Stock Price Chart PepGen Stock Price Chart Akari Therapeutics Stock Price Chart Exicure Stock Price Chart Barinthus Biotherapeutics Stock Price Chart Mersana Therapeutics Stock Price Chart Artiva Biotherapeutics Stock Price Chart Eliem Therapeutics Stock Price Chart Receive ADXN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Addex Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ADXN) was last updated on 7/6/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe day and month stocks are most likely to crash nextGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | Sponsored140% Yields From Stocks Like Tesla? Here's How (July 4th Special)Imagine getting a 140% dividend from your investments. Even better? It works with big names like Tesla, ...Investors Alley | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Addex Therapeutics Ltd. Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Addex Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.